These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8182142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, Fontan G.
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE.
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A.
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [Abstract] [Full Text] [Related]

  • 5. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis.
    Keul R, Heinrich PC, Müller-newen G, Muller K, Woo P.
    Cytokine; 1998 Sep; 10(9):729-34. PubMed ID: 9770335
    [Abstract] [Full Text] [Related]

  • 6. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
    Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, Dayer JM, Vischer T, Guerne PA.
    J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
    De Benedetti F, Pignatti P, Gerloni V, Massa M, Sartirana P, Caporali R, Montecucco CM, Corti A, Fantini F, Martini A.
    J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
    [Abstract] [Full Text] [Related]

  • 10. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [Abstract] [Full Text] [Related]

  • 11. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A, Novick D, Ackerstein A, Or R, Slavin S, Nagler A.
    Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
    [Abstract] [Full Text] [Related]

  • 12. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED, Laxer RM, Nelson DL, Rubin LA.
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [Abstract] [Full Text] [Related]

  • 19. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
    Jouvenne P, Vannier E, Dinarello CA, Miossec P.
    Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
    [Abstract] [Full Text] [Related]

  • 20. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.